Kidney International

FIGURES AND TABLES

FROM:

Impairment of phenylalanine conversion to tyrosine inend-stage renal disease causing tyrosine deficiency

YVES BOIRIE, ROBERT ALBRIGHT, MAUREEN BIGELOW and K SREEKUMARAN NAIR

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 1.

Comparison of phenylalanine flux, tyrosine flux, and phenylalanine conversion to tyrosine (phenylalanine to tyrosine) during saline infusion and amino acid (AA) infusion. (A) Phenylalanine flux were not statistical significantly different between control and end-stage renal disease (ESRD) subjects and in both cases increase occurred with amino acid infusion. (B) Tyrosine flux was lower in ESRD patients than controls during saline and amino acid infusion. (C) Phenylalanine conversion to tyrosine was lower in ESRD patients than controls during saline and during amino acid infusion.

Full figure and legend (22K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Figure 2.

Comparison of phenylalanine conversion to tyrosine as a function of phenylalanine flux and phenylalanine concentration and tyrosine/phenylalanine ration in control and end-stage renal disease (ESRD) subjects. (A) Phenylalanine to tyrosine/phenylalanine flux. (B) Phenylalanine to tyrosine/phenylalanine concentration. (C) Tyrosine/phenylalanine. All these parameters were lower in ESRD patients than in the control subjects.

Full figure and legend (25K)
BACK TO ARTICLE